ATE419862T1 - Interferon-immuntherapie mit niedriger dosis - Google Patents

Interferon-immuntherapie mit niedriger dosis

Info

Publication number
ATE419862T1
ATE419862T1 AT98956636T AT98956636T ATE419862T1 AT E419862 T1 ATE419862 T1 AT E419862T1 AT 98956636 T AT98956636 T AT 98956636T AT 98956636 T AT98956636 T AT 98956636T AT E419862 T1 ATE419862 T1 AT E419862T1
Authority
AT
Austria
Prior art keywords
alpha
malignant tumor
immunotherapy
manufacture
low dose
Prior art date
Application number
AT98956636T
Other languages
English (en)
Inventor
Svetomir Markovic
Original Assignee
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation filed Critical Mayo Foundation
Application granted granted Critical
Publication of ATE419862T1 publication Critical patent/ATE419862T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98956636T 1997-11-07 1998-11-06 Interferon-immuntherapie mit niedriger dosis ATE419862T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6461897P 1997-11-07 1997-11-07

Publications (1)

Publication Number Publication Date
ATE419862T1 true ATE419862T1 (de) 2009-01-15

Family

ID=22057169

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98956636T ATE419862T1 (de) 1997-11-07 1998-11-06 Interferon-immuntherapie mit niedriger dosis

Country Status (8)

Country Link
EP (1) EP1028745B1 (de)
JP (1) JP2001522811A (de)
AT (1) ATE419862T1 (de)
AU (1) AU735094B2 (de)
CA (1) CA2308373A1 (de)
DE (1) DE69840451D1 (de)
ES (1) ES2318875T3 (de)
WO (1) WO1999024060A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770666B2 (en) 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
CZ20013424A3 (cs) 1999-12-27 2002-02-13 Japan Tobacco Inc. Sloučeniny s fúzovanými kruhy a jejich pouľití jako léčiva
EP1118330A1 (de) * 2000-01-19 2001-07-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verwendung von Alpha Interferon zur Behandlung von Ewings Tumoren
AR035543A1 (es) * 2001-06-26 2004-06-16 Japan Tobacco Inc Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
RU2217196C2 (ru) * 2002-02-28 2003-11-27 Небольсин Владимир Евгеньевич Способ индукции дифференцировки клеток

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4846782A (en) * 1986-03-14 1989-07-11 Schering Corporation Treatment of cancer with interferon and radiotherapy

Also Published As

Publication number Publication date
DE69840451D1 (de) 2009-02-26
EP1028745A4 (de) 2004-11-10
ES2318875T3 (es) 2009-05-01
JP2001522811A (ja) 2001-11-20
WO1999024060A1 (en) 1999-05-20
AU1311399A (en) 1999-05-31
EP1028745B1 (de) 2009-01-07
AU735094B2 (en) 2001-06-28
CA2308373A1 (en) 1999-05-20
EP1028745A1 (de) 2000-08-23

Similar Documents

Publication Publication Date Title
AR012614A1 (es) Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento
ATE165000T1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
IT8419266A1 (it) Dispositivo per generare calore in tessuti" del corpo umano e procedimento di cenerazione di calore, particolarmente per la cura di tumori
CY1112361T1 (el) Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743
IL157504A0 (en) Oncolytic virus therapy
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
MY164077A (en) Compositions and uses of et743 for treating cancer
PL311660A1 (en) Viral vectors and their application in genic therapy
ES2162927T3 (es) Formulacion para la aplicacion por inhalacion.
GEP20043251B (en) Use of CYP2D6 Inhibitors in Combination Therapies
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ATE104152T1 (de) Verringerung der nebeneffekte bei der krebstherapie.
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
AR043071A1 (es) Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica
MX9708803A (es) Compuestos biaromaticos de propinilo o dienilo.
GEP20043202B (en) Resorcinol Derivatives
BR9814419A (pt) "combinação de compostos de benzociclo-heptapiridina e drogas antineopláticas para tratamento de doenças proliferativas"
DE69840451D1 (de) Interferon-immuntherapie mit niedriger dosis
ATE170075T1 (de) Antivirales arzneimittel enthaltend prostratin
GR3033319T3 (en) Products for the application of high initial doses of cetrorelix and preparation of a combined package for use in treating diseases.
DE69918961D1 (de) Verbesserte inhalationspräparate
PL368686A1 (en) Novel aminobenzoephenones
ATE454139T1 (de) Arzneimittel mit shikonin als wirkstoff
UY26595A1 (es) Formulaciones de entecavir de dosis bajas y uso
MXPA03010709A (es) Producto nuevo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties